QIAGEN N.V. has announced that it has acquired licenses from Roche, as well as from Ortho Clinical Diagnostics. These two license agreements significantly expand QIAGEN's rights to real-time ...
The Brilliant III Ultra-Fast QPCR and QRT-PCR Master Mix reagents are designed to provide the fastest cycling times on any real-time PCR instrument. These reagents feature a newly engineered Taq, ...
Pune, March 24, 2023 (GLOBE NEWSWIRE) -- SNS Insider reports states that the Real-Time PCR (qPCR) Market had a valuation of USD 5.2 billion in 2022 and is projected to achieve USD 8.07 billion by 2030 ...
Today's research on somatic, genetic and epigenetic variation in eukaryotic cells requires fast, accurate and cost-effective methods for screening large numbers of samples or loci in parallel.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback